Dashboard
Manage Tickers

ANVS


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
10/10/2025 17:06:47

annovis-bio-announces-6m-registered-direct-offering-of-common-stock-and-pre-funded-warrants-targeting-october-13-close-for-neurodegeneration-focused-platform
Annovis Bio Announces $6M Registered Direc...
10/10/2025 12:36:43

Annovis Bio, Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneer...

annovis-bio-announces-results-showing-buntanetaps-ability-to-attenuate-inflammation-and-improve-cellular-health-in-alzheimers-patients-suggesting-potential-disease-modifying-treatment
Annovis Bio Announces Results Showing Bunt...
10/09/2025 11:34:07

canaccord-genuity-maintains-buy-on-annovis-bio-maintains-17-price-target
Canaccord Genuity Maintains Buy on Annovis...
09/30/2025 13:41:11

Canaccord Genuity analyst Sumant Kulkarni maintains Annovis Bio (NYSE:ANVS) with a Buy and maintains $17 price target.

annovis-bio-appoints-mark-guerin-as-cfo
Annovis Bio Appoints Mark Guerin As CFO
09/25/2025 11:37:09

annovis-bio-highlights-new-buntanetap-form-in-phase-3-alzheimers-trial-extends-patent-protection-into-2040s
Annovis Bio Highlights New Buntanetap Form...
09/16/2025 11:38:43

Annovis Bio, Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneer...

alphabet-to-rally-around-23-here-are-10-top-analyst-forecasts-for-wednesday
Alphabet To Rally Around 23%? Here Are 10 ...
09/03/2025 12:25:40

hc-wainwright--co-maintains-buy-on-annovis-bio-lowers-price-target-to-10
HC Wainwright & Co. Maintains Buy on Annov...
09/03/2025 10:56:11

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Annovis Bio (NYSE:ANVS) with a Buy and lowers the price target ...

annovis-bio-q2-eps-032-beats-040-estimate
Annovis Bio Q2 EPS $(0.32) Beats $(0.40) E...
08/12/2025 20:37:11

Annovis Bio (NYSE:ANVS) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.40) by ...

annovis-transfers-full-patent-to-crystal-buntanetap
Annovis Transfers Full Patent To Crystal B...
08/07/2025 12:06:06

Annovis achieves comprehensive intellectual property (IP) protection now covering both the original semi-crystalline and new cr...

why-medpace-shares-are-trading-higher-by-45-here-are-20-stocks-moving-premarket
Why Medpace Shares Are Trading Higher By 4...
07/22/2025 09:39:38

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
06/25/2025 17:06:36

annovis-bio-announces-it-received-nyse-acceptance-letter-granting-the-co-18-month-period-to-maintain-listing
Annovis Bio Announces It Received NYSE Acc...
06/19/2025 10:38:15

Annovis Bio, Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneer...

hc-wainwright--co-maintains-buy-on-annovis-bio-lowers-price-target-to-12
HC Wainwright & Co. Maintains Buy on Annov...
06/09/2025 12:00:13

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Annovis Bio (NYSE:ANVS) with a Buy and lowers the price target ...

Core News & Articles
'FDA Clears First Blood Test Used In Diagn...
05/16/2025 17:32:57

https://www.fda.gov/news-events/press-announcements/fda-clears-first-blood-test-used-diagnosing-alzheimers-disease#:~:text=The%...

levi-strauss-to-rally-around-20-here-are-10-top-analyst-forecasts-for-thursday
Levi Strauss To Rally Around 20%? Here Are...
05/15/2025 12:32:50

canaccord-genuity-maintains-buy-on-annovis-bio-lowers-price-target-to-17
Canaccord Genuity Maintains Buy on Annovis...
05/15/2025 12:14:44

Canaccord Genuity analyst Sumant Kulkarni maintains Annovis Bio (NYSE:ANVS) with a Buy and lowers the price target from $26 ...

annovis-bio-q1-eps-032-beats-036-estimate
Annovis Bio Q1 EPS $(0.32) Beats $(0.36) E...
05/13/2025 20:47:25

Annovis Bio (NYSE:ANVS) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.36) by ...

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
04/21/2025 21:05:49

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
04/21/2025 17:05:41

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION